Filing Details
- Accession Number:
- 0001127602-19-034301
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-04 19:25:29
- Reporting Period:
- 2019-12-02
- Accepted Time:
- 2019-12-04 19:25:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc. | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1575229 | Charles Dadswell | 5200 Illumina Way San Diego CA 92122 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-02 | 655 | $320.33 | 3,576 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Since the date of the last ownership report, 18 shares of Illumina common stock have been transferred pursuant to a domestic relations order. The reporting person no longer reports as the beneficial owner of these securities.
Billionaire Hedge Funds
